Navigation Links
LABS, Inc. Earns AABB Accreditation for Donor Testing
Date:1/6/2012

CENTENNIAL, Colo., Jan. 6, 2012 /PRNewswire/ -- LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, today announced that it has been granted AABB Accreditation for donor testing. The voluntary accreditation program contributes to the quality and safety of collecting, processing, testing, distributing and administering blood and cellular therapy products.

LABS' accreditation follows an intensive on-site assessment by specially trained AABB assessors that established that the level of technical and administrative performance within the facility met or exceeded the standards set by AABB. By successfully meeting those requirements, LABS joins an elite group of facilities that have taken this extra step in quality principles. The accreditation program has been recognized by the International Society for Quality in Healthcare (ISQua).

"LABS sought the voluntary AABB Accreditation because the program helps us achieve excellence by promoting a level of professional and technical expertise that contributes to quality performance and patient safety," said Elizabeth Hearty, Chief Executive Officer of LABS, Inc. "LABS already has a trusted record of personalized service, compliance and integrity, and this accreditation is another demonstration of our absolute dedication to creating outstanding patient outcomes."

LABS, Inc. is the leading donor eligibility testing laboratory in the nation. The Company obtained this industry leadership position in the donation community by providing highly customized solutions using the most innovative technologies, delivering precise results, and maintaining an unmatched attention to customer service and quality.  The Company is committed to respectfully fulfilling the wishes of donors by ensuring their gifts are quickly and effectively screened so that they may go on to help patients in need.

About LABS, Inc.
LABS, Inc. is a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices. LABS provides an intimate customer service experience, which results in personalized laboratory solutions for clients in any stage of the product development lifecycle: donor eligibility, R&D, processing and validation and final lot release. 

LABS has an established and trusted record of personalized service, compliance and integrity. The Company serves a variety of industries that are focused on advancing and understanding biologic-based products.

The company is headquartered in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA. LABS receives sample shipments from across the globe and performs testing for 10 nations outside of the U.S.: Australia (TGA certified), Singapore, Korea, Canada, Mexico, Brazil, Ecuador, England, Germany and Italy.  To learn more, visit www.labs-inc.org.

About AABB
Established in 1947, AABB (formerly known as the American Association of Blood Banks) is an international, not-for-profit association representing individuals and institutions involved in the field of transfusion medicine and related biologic therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programs and services to optimize patient and donor care and safety.


'/>"/>
SOURCE LABS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
2. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
3. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
4. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
5. GeoVax Labs, Inc. Announces First Quarter Financial Results
6. GeoVax Labs, Inc. Announces Resignation of Director
7. GeoVax Labs, Inc. Provides Clinical Studies Update
8. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
9. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
10. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
11. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... July 20, 2017   KCNQ2 Cure Alliance ... evaluations company, today announced that they have completed ... genetic mutation implicated in KCNQ2 epileptic encephalopathy. They ... a second case involving an additional KCNQ2 genetic ... Alliance and Pairnomix entered into a collaboration to ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to make clinical trial sites and study participants truly unified. TrialKit, a native ... (FDA 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, ...
(Date:7/18/2017)... ... July 18, 2017 , ... Sourcing custom glass or quartz parts can be ... capabilities to properly execute your job can take many hours of emails, phone calls ... portal designed to showcase the company’s capabilities and core custom categories, and enables you ...
(Date:7/18/2017)... ... , ... G-CON today announced that it has received Notices ... Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean Room. The U.S. ... of G-CON’s R&D investments and validate the G-CON platform as a novel way ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):